Find uplifting stories about heroes, innovations, and solutions
21064 results for "fda compassionate use"
Eli Lilly has granted one person extraordinary access to its next-generation obesity treatment through an FDA compassionate use program. The decision marks a rare exception that could offer hope to patients waiting for breakthrough treatments.
The FDA just launched a pilot program to use artificial intelligence to make life-saving clinical trials faster and more efficient. Two major drug companies are already testing treatments in real time using the new system.
A headset that uses gentle electrical pulses to treat depression just won FDA approval for home use. The device offers a medication-free option for millions struggling with mental health.
The FDA approved leucovorin for cerebral folate deficiency, a rare genetic brain disorder affecting fewer than one in a million people. The decision brings clarity after months of confusion about the drug's potential uses.
Americans will finally get access to a sunscreen ingredient Europe has used for decades, ending a 25-year gap in product innovation. The FDA's approval of bemotrizinol marks a major shift toward faster approval of safe, effective products.
For the first time in three decades, patients with inoperable pancreatic cancer have a new treatment option. The FDA just approved Optune Pax, a wearable device you use at home that uses electric fields to kill cancer cells.
The FDA is accelerating breakthrough psychedelic therapies for treatment-resistant depression, PTSD, and alcohol use disorder after a presidential directive. Veterans and millions struggling with serious mental illness could gain access to promising new options backed by rigorous science.
A groundbreaking gene-editing treatment could reach patients faster than ever before, as Prime Medicine asks the FDA to approve their therapy after just two successful treatments. The drug uses a revolutionary CRISPR technique to fix a genetic disorder that leaves patients vulnerable to deadly infections.
After a quarter century without updates, the FDA just approved bemotrizinol, a powerful UV filter used in Europe since 1999. Americans will finally get access to better sun protection that's been available worldwide for decades.
%3Amax_bytes(150000)%3Astrip_icc()%2F2208-05-074_cattle-0930040062ba48a497b4d462c206b168.jpg)
Ranchers and farmers now have better tools to protect their animals from a dangerous parasite that's been threatening U.S. livestock. The FDA just approved new sizes and expanded use of the only over-the-counter treatment available.
A Minnesota company just won FDA approval for a breakthrough prostate cancer treatment that uses steam instead of surgery. The 30-minute outpatient procedure could help 84% of newly diagnosed patients avoid invasive treatments.
A small facial patch that uses "sleep sonar" to pinpoint exactly where and why airways collapse during sleep just earned FDA breakthrough status. The AI-powered device could help 39 million Americans with sleep apnea get treatments tailored to their specific obstruction patterns.
A new AI platform just got FDA clearance to help doctors and patients make breast cancer treatment choices in days instead of weeks. ArteraAI Breast uses regular pathology slides to predict which patients need chemotherapy, potentially saving time and money.
For the first time, Americans with depression can use a prescription brain-stimulation device at home, marking a breakthrough for the 7 million people who don't respond to traditional medication. The FDA-approved headset delivers gentle electrical currents to restore healthier brain activity in just 30 minutes a day.
For the first time, Americans can treat depression at home using a headset that gently stimulates the brain with electricity. The FDA's approval of this medication-free approach marks a major shift in mental health care.
For the first time in three decades, the FDA has approved a new treatment for locally advanced pancreatic cancer that extends survival and reduces pain. The wearable device uses electric fields instead of drugs to target cancer cells.
A groundbreaking depression treatment using psilocybin is showing promising results in clinical trials, potentially becoming the first psychedelic therapy approved by the FDA. Two major studies confirm the compound helps patients with severe depression find relief.
A generic medication used in cancer care has received FDA fast-track approval as the first new autism treatment in years, offering families like the Wilsons of Las Vegas a fresh path forward. Seven-year-old Christopher is among the first Nevada children trying leucovorin, dubbed "the little bottle of hope" by parents seeking answers.
A Swiss brown cow in Austria has stunned scientists by using a broom as a tool, carefully selecting which end to use based on where she wants to scratch. This is the first documented case of a cow not only using a tool but adjusting it for different body parts.
The FDA just announced a new pathway that could bring life-saving gene editing treatments to patients with rare diseases in record time. For families battling conditions once considered untreatable, this could change everything.
Showing 20 of 21064